CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-20 | Singleton Mark Leonard SVP & CFO | Shares withheld for taxes | −8,091 | $8.64 | $70K | 169,981 |
| 2026-03-20 | Singleton Mark Leonard SVP & CFO | Option exercise · Restricted Stock Units | −18,625 | 0 | ||
| 2026-03-13 | Claypoole Robert E President and CEO | Option exercise | +33,500 | 150,497 | ||
| 2026-03-13 | Claypoole Robert E President and CEO | Shares withheld for taxes | −14,553 | $8.62 | $125K | 135,944 |
| 2026-03-13 | Claypoole Robert E President and CEO | Grant or award · Restricted Stock Units | +278,000 | 278,000 | ||
| 2026-03-13 | Claypoole Robert E President and CEO | Grant or award · Stock Option (Right to Buy) | +309,000 | 309,000 | ||
| 2026-03-13 | Claypoole Robert E President and CEO | Option exercise · Restricted Stock Units | −33,500 | 100,500 | ||
| 2026-03-13 | Singleton Mark Leonard SVP & CFO | Option exercise | +13,500 | 165,312 | ||
| 2026-03-13 | Singleton Mark Leonard SVP & CFO | Shares withheld for taxes | −5,865 | $8.62 | $51K | 159,447 |
| 2026-03-13 | Singleton Mark Leonard SVP & CFO | Grant or award · Restricted Stock Units | +104,000 | 104,000 | ||
| 2026-03-13 | Singleton Mark Leonard SVP & CFO | Grant or award · Stock Option (Right to Buy) | +116,000 | 116,000 | ||
| 2026-03-13 | Singleton Mark Leonard SVP & CFO | Option exercise · Restricted Stock Units | −13,500 | 40,500 | ||
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Option exercise | +8,886 | 146,955 | ||
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Shares withheld for taxes | −3,861 | $8.62 | $33K | 143,094 |
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Option exercise | +8,750 | 151,844 | ||
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Shares withheld for taxes | −3,802 | $8.62 | $33K | 148,042 |
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Grant or award · Restricted Stock Units | +83,000 | 83,000 | ||
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +92,000 | 92,000 | ||
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Option exercise · Restricted Stock Units | −8,886 | 0 | ||
| 2026-03-13 | D'Adamio Anthony SVP & General Counsel | Option exercise · Restricted Stock Units | −8,750 | 26,250 |
Page 3 of 22 · 437 trades